TW284787B - - Google Patents
Info
- Publication number
- TW284787B TW284787B TW082110648A TW82110648A TW284787B TW 284787 B TW284787 B TW 284787B TW 082110648 A TW082110648 A TW 082110648A TW 82110648 A TW82110648 A TW 82110648A TW 284787 B TW284787 B TW 284787B
- Authority
- TW
- Taiwan
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
- C12Y102/01012—Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) (1.2.1.12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
- C12Y102/01013—Glyceraldehyde-3-phosphate dehydrogenase (NADP+) (phosphorylating) (1.2.1.13)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
- G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
- G01N2333/395—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Saccharomyces
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- High Energy & Nuclear Physics (AREA)
- Mycology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/999,071 US5691196A (en) | 1992-12-31 | 1992-12-31 | Recombinant nucleic acid containing a response element |
Publications (1)
Publication Number | Publication Date |
---|---|
TW284787B true TW284787B (zh) | 1996-09-01 |
Family
ID=25545860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW082110648A TW284787B (zh) | 1992-12-31 | 1993-12-15 |
Country Status (6)
Country | Link |
---|---|
US (4) | US5691196A (zh) |
EP (1) | EP0608532A3 (zh) |
JP (1) | JPH06292580A (zh) |
KR (1) | KR940014779A (zh) |
CA (1) | CA2112527A1 (zh) |
TW (1) | TW284787B (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0813604B1 (en) | 1995-03-03 | 2005-04-20 | Syngenta Participations AG | Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
FR2735370B1 (fr) * | 1995-06-19 | 1997-07-18 | Cird Galderma | Procede pour identifier des composes agonistes des recepteurs rxrs |
AU6924196A (en) * | 1995-09-20 | 1997-04-09 | Novo Nordisk A/S | New furyl-pyridone compounds, useful as fungicides and obtained from the fungus cladobotryum |
CN1202202A (zh) | 1995-10-10 | 1998-12-16 | 诺瓦提斯公司 | 保幼激素或其激动剂之一作为以受体介导的反式激活控制植物基因表达的化学配体 |
CA2350599A1 (en) * | 1998-11-20 | 2000-06-02 | Genentech, Inc. | Method of inhibiting angiogenesis |
TR200504220T2 (tr) | 1998-12-17 | 2007-04-24 | Biogen Idec Ma Inc. | Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem. |
AU3349900A (en) * | 1999-01-26 | 2000-08-07 | Du Pont Pharmaceuticals Company | Electrophoretic assays to assess conformational changes of integrins induced by ligand binding |
WO2001016597A1 (en) * | 1999-09-01 | 2001-03-08 | Institut National De La Sante Et De La Recherche Medicale | In vitro transcription systems and uses |
AU2001234444A1 (en) * | 2000-01-13 | 2001-07-24 | Tularik, Inc. | Car modulators: screening and treatment of hypercholesterolemia |
US6432427B1 (en) * | 2000-06-30 | 2002-08-13 | Unilever Hope & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic compositions containing substituted sulfonamide derivatives |
ES2360205T3 (es) * | 2001-03-02 | 2011-06-01 | Agennix Ag | Sistema de ensayo de tres híbridos. |
US20020193403A1 (en) * | 2001-05-03 | 2002-12-19 | Allergan Sales, Inc. | Methods of treating hyperlipidemia |
US6921762B2 (en) * | 2001-11-16 | 2005-07-26 | Amgen Inc. | Substituted indolizine-like compounds and methods of use |
US7223726B2 (en) * | 2002-01-14 | 2007-05-29 | The Regents Of The University Of California | Apolipoprotein A-I mutant proteins having cysteine substitutions and polynucleotides encoding same |
US20030155328A1 (en) * | 2002-02-15 | 2003-08-21 | Huth Mark C. | Laser micromachining and methods and systems of same |
US20030170724A1 (en) * | 2002-03-08 | 2003-09-11 | Anderson David C. | Methods of identifying target polypeptides |
KR100492514B1 (ko) * | 2002-05-03 | 2005-06-03 | 학교법인 포항공과대학교 | 레티노산에 의해 발현이 조절되는 재조합 리포터 유전자를가지는 형질전환 세포주 및 이를 이용한 레티노산유사물질 및 저해물질의 생물학적 검색방법 |
EA200900581A1 (ru) | 2006-10-20 | 2009-08-28 | Байоджен Айдек Эмэй Инк. | Способ лечения демиелинизирующего заболевания (варианты), способ стимулирования ремиелинизации, доставочное устройство (варианты) и набор, способ инструктирования больного, страдающего демиелинизирующим заболеванием |
US8338376B2 (en) | 2006-10-20 | 2012-12-25 | Biogen Idec Ma Inc. | Compositions comprising variant LT-B-R-IG fusion proteins |
JP5226353B2 (ja) * | 2008-03-26 | 2013-07-03 | 長瀬産業株式会社 | 形質転換酵母、それを用いた分析方法および分析キット |
JP6295249B2 (ja) | 2012-06-07 | 2018-03-14 | チルドレンズ ホスピタル ロサンゼルス | レチノイドアゴニストを用いた好中球減少症の治療方法 |
CA2937340C (en) | 2014-02-18 | 2022-06-14 | Children's Hospital Los Angeles | Compositions and methods for treating neutropenia |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8826062D0 (en) * | 1988-11-07 | 1988-12-14 | Raychem Sa Nv | Splice case for optical fibre cable |
EP0441483A3 (en) * | 1990-01-16 | 1992-11-19 | Baylor College Of Medicine | Expression vectors that produce steroid receptors, steroid receptor chimera, screening assays for steroid receptors and clinical assays using synthesized receptors and receptor vectors |
US5552271A (en) * | 1992-06-16 | 1996-09-03 | La Jolla Cancer Research Foundation | RXR homodimer formation |
-
1992
- 1992-12-31 US US07/999,071 patent/US5691196A/en not_active Expired - Fee Related
-
1993
- 1993-12-13 EP EP93120050A patent/EP0608532A3/en not_active Withdrawn
- 1993-12-15 TW TW082110648A patent/TW284787B/zh active
- 1993-12-29 JP JP5349809A patent/JPH06292580A/ja active Pending
- 1993-12-29 CA CA002112527A patent/CA2112527A1/en not_active Abandoned
- 1993-12-30 KR KR1019930032310A patent/KR940014779A/ko not_active Application Discontinuation
-
1995
- 1995-06-06 US US08/465,783 patent/US5700682A/en not_active Expired - Fee Related
- 1995-06-06 US US08/469,122 patent/US5700650A/en not_active Expired - Fee Related
- 1995-06-06 US US08/469,120 patent/US5714595A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5700682A (en) | 1997-12-23 |
EP0608532A3 (en) | 1995-11-15 |
KR940014779A (ko) | 1994-07-19 |
US5691196A (en) | 1997-11-25 |
US5714595A (en) | 1998-02-03 |
CA2112527A1 (en) | 1994-07-01 |
EP0608532A2 (en) | 1994-08-03 |
US5700650A (en) | 1997-12-23 |
JPH06292580A (ja) | 1994-10-21 |